Description
Includes the most relevant genes for arrhythmias, congenital heart disease, and cardiomyopathies. Syndromes included: Long and short QT, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, cardiomyopathies dilated and hypertrophic, and congenital heart defects. In addition, this panel includes vascular abnormalities, such as dolichoectasia and hereditary hemorragic telangiectasia.
Test code(s)
BNG-620, BNG-634
TAT
Contact us for more information
Method
NGS (Next-Generation Sequencing)/MLPA/Sanger Sequencing/PCR
Accepted Sample requirements
A prior consultation at BION is necessary to evaluate the feasibility and plan for PGT-M.
- A pre-PGT-M analysis is mandatory. Samples such as blood sample from the couple and potentially other family members will be required as part of the genetic consultation process.
- The PGT-M procedure allows for a blastocyst biopsy on days 5, 6, or 7 of embryo development. A sample of 4-8 trophectoderm cells is needed for testing. In certain cases, a biopsy on day 3 may be considered upon request.